NeuroFlex Podcast
The NeuroFlex Podcast is an applied neuroscience show which features unfiltered, raw conversations with neurotherapists, biohackers, psychologists, and neuroscientists. NeuroFlex gives remarkable individuals a platform to communicate their thoughts and ideas freely, and engage in deep, meaningful discussions with the host.
NeuroFlex Podcast
Christopher J. Moreau: DMT, Neuroplasticity & Stroke Recovery | Episode 200
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
Mr. Moreau is the CEO of Algernon Pharmaceuticals Inc. and a member of the company's board of directors. With over 30 years of executive management experience overall, including 15 years in CEO roles, he has proven achievements in operations management, acquisitions, licensing, and integration.
Algernon Pharmaceuticals plans to be the first Company globally to pursue DMT for stroke in humans and is planning to begin a clinical trial as soon as possible this year. DMT is a "classic" psychedelic compound part of the tryptamine family.
https://algernonpharmaceuticals.com
